Hypothyroidism and Infertility

Thyroid physiology and reproductive endocrinology are tightly linked. The hypothalamus secretes TRH to stimulate pituitary TSH, which drives thyroidal T4 and T3 production. These hormones feed back on both the hypothalamic‑pituitary‑thyroid (HPT) and hypothalamic‑pituitary‑gonadal (HPG) axes. In hypothyroidism, reduced T4/T3 prompts higher TRH, which can increase prolactin; elevated prolactin suppresses GnRH pulsatility, contributing to anovulation, luteal phase insufficiency, and menstrual irregularities. Thyroid receptors in ovarian tissue and the endometrium reflect direct roles for T3 in follicle development and endometrial receptivity. In men, thyroid dysfunction can reduce libido, alter testosterone and SHBG dynamics, and impair semen volume, motility, and morphology—changes that often improve after euthyroidism is restored. Clinically, the bridge between hypothyroidism and infertility is strongest for overt hypothyroidism, where treatment with levothyroxine restores ovulation and reduces miscarriage. Subclinical hypothyroidism is more nuanced: data on natural fecundity and ART outcomes are mixed, yet many specialists consider treatment when TSH is ≥4.0 mIU/L or when ART is planned. Thyroid autoimmunity (TPO antibodies) is common among infertile patients and is associated with miscarriage, but a large randomized trial showed no improvement in live‑birth with levothyroxine for euthyroid, antibody‑positive women. Workup typically includes TSH (first‑line), free T4 to gauge severity, and TPO antibodies to establish autoimmune etiology; prolactin measurement can explain ovulatory dysfunction. Differential diagnoses include PCOS, hyperprolactinemia from other causes, hypothalamic amenorrhea, primary ovarian insufficiency, and male or uterine factors. Preconception management aims for biochemical euthyroidism, with many guidelines targeting a TSH under about 2.5 mIU/L prior to and during the first trimester. In those using ART, cycle timing is often coordinated once thyroid levels are stable. During pregnancy, untreated hypothyroidism increases risks of miscarriage, hypertensive disorders, preterm birth, and impaired fetal neurodevelopment; early monitoring and dose adjustments of thyroid hormone are standard. Adjunctive considerations include ensuring iodine adequacy (especially in deficient regions), addressing iron deficiency, supporting healthy weight, and mitigating environmental endocrine disruptors. Collaboration between endocrinology and reproductive medicine maximizes the likelihood of conception and healthy pregnancy outcomes.

Traditional frameworks approach infertility and hypothyroidism as manifestations of systemic imbalance affecting vital energy, heat, and fluid dynamics. In Traditional Chinese Medicine (TCM), symptoms such as fatigue, coldness, weight gain, and irregular menses often reflect Kidney yang and Spleen qi deficiency with Phlegm‑Damp accumulation. These patterns can correspond to anovulation and suboptimal endometrial receptivity. Treatment principles seek to warm and tonify Kidney yang, strengthen Spleen qi, resolve Phlegm, and harmonize the Chong and Ren vessels. Acupuncture and moxibustion are used to regulate the HPO axis, improve uterine and ovarian blood flow, and reduce stress—mechanisms that modern studies suggest can influence autonomic tone and neuroendocrine signaling. While data for improved live‑birth rates remain inconsistent, many patients report cycle regularization and reduced stress—supportive elements during conception efforts. Ayurveda typically interprets hypothyroid states as Kapha predominance with Vata disturbance and diminished Agni (metabolic fire). Strategies emphasize warming, digestively supportive foods, daily routines, sleep regularity, and individualized botanicals. Naturopathic and integrative perspectives echo these whole‑person approaches, prioritizing nutrient sufficiency—iodine where intake is inadequate, selenium, iron, and vitamin D—along with stress‑modulating practices such as yoga, meditation, and breathwork. These modalities aim to optimize the terrain in which endocrine and reproductive systems interact. Across these traditions, the emphasis is on restoring balance rather than targeting a single lab value. Importantly, integrative practitioners increasingly coordinate with endocrinologists and reproductive specialists so that supportive therapies complement, rather than replace, evidence‑based treatments like levothyroxine and ART. This collaborative model respects the role of thyroid hormones in reproductive health while offering additional avenues—dietary, lifestyle, mind‑body, and gentle botanical supports—to enhance well‑being and potentially improve the experience and outcomes of those seeking to conceive.